Literature DB >> 21248072

Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry.

Hedwig C M Stepman1, An Vanderroost, Katleen Van Uytfanghe, Linda M Thienpont.   

Abstract

BACKGROUND: 25-hydroxyvitamin D [25(OH)D] assays are characterized by poor between-assay comparability. This result emphasizes the need for reference measurement procedures (RMPs) to establish calibration traceability and assist in method validation. We aimed at developing candidate RMPs on the basis of isotope- dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) for separate quantification of serum 25(OH)D2 and 25(OH)D3.
METHODS: Hexa-deuterated 25(OH)D3/D2 was added to serum. This mixture was extracted with n-hexane and fractionated on Sephadex LH-20 before 2-dimensional LC-MS/MS. In the first dimension, both procedures used a C4 column; however, in the second dimension, the 25(OH)D2 procedure used a C18 and the 25(OH)D3 procedure used a Zorbax SB-CN column. Calibration was traceable to the NIST Standard Reference Material (SRM) 2972. Validation comprised assessment of interference and limit of quantification/detection. Imprecision and trueness were validated by analysis of the SRM 972 against specifications (CV<5% and bias<1.7%). The expanded uncertainty for quadruplicate measurements was estimated.
RESULTS: Testing of potentially interfering substances was negative. Interference by 3-epi-25(OH)D3 was resolved by sufficient chromatographic resolution. The limits of quantification/detection were 1.1 nmol/L and 0.09 pmol/L for 25(OH)D3 and 1.2 nmol/L and 0.05 pmol/L for 25(OH)D(2). Mean total CVs and differences from the SRM 972 target (±1-sided 95% CI) were 2.1% and 1.1%±1.5% [25(OH)D3] and 3% and 1.3%±0.6% [25(OH)D2], respectively. The respective expanded uncertainties were 3.4% and 3.9%.
CONCLUSIONS: From the validation data, we conclude that we achieved our objective of 2 state-of-the-art candidate RMPs for serum 25(OH)D3 and 25(OH)D2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248072     DOI: 10.1373/clinchem.2010.152553

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  69 in total

1.  Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey.

Authors:  Kurtis Sarafin; Ramón Durazo-Arvizu; Lu Tian; Karen W Phinney; Susan Tai; Johanna E Camara; Joyce Merkel; Evan Green; Christopher T Sempos; Stephen P J Brooks
Journal:  Am J Clin Nutr       Date:  2015-09-30       Impact factor: 7.045

2.  Accurate and reliable quantification of 25-hydroxy-vitamin D species by liquid chromatography high-resolution tandem mass spectrometry.

Authors:  Gerhard Liebisch; Silke Matysik
Journal:  J Lipid Res       Date:  2015-04-01       Impact factor: 5.922

3.  Development and comparison of three liquid chromatography-atmospheric pressure chemical ionization/mass spectrometry methods for determining vitamin D metabolites in human serum.

Authors:  Mary Bedner; Karen W Phinney
Journal:  J Chromatogr A       Date:  2012-04-05       Impact factor: 4.759

4.  Standardization of measurements of 25-hydroxyvitamin D3 and D2.

Authors:  Linda M Thienpont; Hedwig C M Stepman; Hubert W Vesper
Journal:  Scand J Clin Lab Invest Suppl       Date:  2012

Review 5.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Authors:  Christopher T Sempos; Annemieke C Heijboer; Daniel D Bikle; Jens Bollerslev; Roger Bouillon; Patsy M Brannon; Hector F DeLuca; Glenville Jones; Craig F Munns; John P Bilezikian; Andrea Giustina; Neil Binkley
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

6.  National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.

Authors:  Rosemary L Schleicher; Maya R Sternberg; Anne C Looker; Elizabeth A Yetley; David A Lacher; Christopher T Sempos; Christine L Taylor; Ramon A Durazo-Arvizu; Khin L Maw; Madhulika Chaudhary-Webb; Clifford L Johnson; Christine M Pfeiffer
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

Review 7.  Fat-Soluble Vitamins: Clinical Indications and Current Challenges for Chromatographic Measurement.

Authors:  Ali A Albahrani; Ronda F Greaves
Journal:  Clin Biochem Rev       Date:  2016-02

8.  Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study.

Authors:  Jean-Claude Souberbielle; Catherine Massart; Sylvie Brailly-Tabard; Etienne Cavalier; Philippe Chanson
Journal:  Endocrine       Date:  2016-04-22       Impact factor: 3.633

9.  Various calibration procedures result in optimal standardization of routinely used 25(OH)D ID-LC-MS/MS methods.

Authors:  Niek F Dirks; Hubert W Vesper; Antonius E van Herwaarden; Jody M W van den Ouweland; Ido P Kema; Johannes G Krabbe; Annemieke C Heijboer
Journal:  Clin Chim Acta       Date:  2016-08-25       Impact factor: 3.786

Review 10.  Vitamin D and metabolites measurement by tandem mass spectrometry.

Authors:  Johannes M W van den Ouweland; Michael Vogeser; Silvia Bächer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.